| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/17/2004 | EP1140810B1 Benzenic sulphonamide derivatives and their uses |
| 03/17/2004 | EP1137644B9 Benzofuran derivatives, their preparation and use |
| 03/17/2004 | EP1137497B1 Apparatus for separating particles of cohesive material according to size and process |
| 03/17/2004 | EP1135391B1 Novel triazolo(4,5-d)pyrimidine compounds |
| 03/17/2004 | EP1100792B1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 03/17/2004 | EP1047695B1 Novel bispidine antiarrhythmic compounds |
| 03/17/2004 | EP0951471B1 Cycloalkyl inhibitors of protein farnesyltransferase |
| 03/17/2004 | EP0915974B1 Modified tie-2-receptor ligands |
| 03/17/2004 | EP0891362B1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
| 03/17/2004 | EP0891332B1 6-phenylpyridyl-2-amine derivatives |
| 03/17/2004 | CN1483040A Heart ankyrin repeat protein gene upstream sequence, carrier containing the same sequence and usage thereof |
| 03/17/2004 | CN1483039A Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents |
| 03/17/2004 | CN1483035A Sulfamidothienopyrimidines |
| 03/17/2004 | CN1483034A Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands |
| 03/17/2004 | CN1483032A Process for making substituted 8-arylquinolinium benzenesulfonate |
| 03/17/2004 | CN1483029A Sodium channel modulators derived from 2-piperidylimidazoles |
| 03/17/2004 | CN1483026A Benzoylpyridazine |
| 03/17/2004 | CN1483023A 3-arylindole derivatives and their use as cb2 receptor agonists |
| 03/17/2004 | CN1483021A Novel 1, 2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism |
| 03/17/2004 | CN1482918A Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders |
| 03/17/2004 | CN1482917A New therapeutic uses of smr1 peptides |
| 03/17/2004 | CN1482913A Purine ribosides as antiarrhythmics |
| 03/17/2004 | CN1482912A Heteroaryl urea neuropeptide yy5 receptor antagonists |
| 03/17/2004 | CN1482909A Thermoformable solid pharmaceutical composition for controlled release of perindopril |
| 03/17/2004 | CN1482906A New clinical treatment |
| 03/17/2004 | CN1482901A Solid themoformable pharmaceutical composition for the controlled release of ivabradine |
| 03/17/2004 | CN1482139A Mucroslysin protein and gene thereof |
| 03/17/2004 | CN1482136A Extract of american ginseng fruit saponin, extracting and refining method and medicinal use thereof |
| 03/17/2004 | CN1481884A Skin-infiltrating film of Chinese traditional medicine for curing paralysis resulting from central nerve trauma and its preparation method |
| 03/17/2004 | CN1481883A Fleabane soft capsule formulation and its preparation method |
| 03/17/2004 | CN1481882A Red peony root injection and its preparation method |
| 03/17/2004 | CN1481831A Phospholipid liposome oral fluid |
| 03/17/2004 | CN1481809A Sodium bialginate for injection and its preparation method |
| 03/17/2004 | CN1481806A Injection formulation of astragalus root saponin and its preparation method |
| 03/17/2004 | CN1481800A Dimaltol vanadium complex tablet formulation for d iabetes and its use |
| 03/17/2004 | CN1481799A Granule, capsule formulation of dimaltol vanadium complex for Diabetes and its use |
| 03/17/2004 | CN1481798A Large capacity gingko damole injection and its preparation method |
| 03/17/2004 | CN1481793A Ginkgo leaf extract and injection fluid containing same |
| 03/17/2004 | CN1481789A Medicine for curing angiocardiopathy and specialty of ophthalmology |
| 03/17/2004 | CN1481787A Propylgallate injection and its preparing process |
| 03/17/2004 | CN1481786A Method for preparing sotalol hydrochloride of injection |
| 03/17/2004 | CN1142278C Prourokinase variant capable of being activated by urokinase or itself and coding gene, preparing method and use thereof |
| 03/17/2004 | CN1142157C Thenoyl piperazine derivative with positive myodyamia effect |
| 03/17/2004 | CN1142153C Benzoylpyridazines |
| 03/17/2004 | CN1142144C 4-phenyl pyridine derivatives |
| 03/17/2004 | CN1141965C Medicine for treating heart disease |
| 03/17/2004 | CN1141963C Ointment for curing hemorrhoids |
| 03/17/2004 | CN1141958C Pile treating medication |
| 03/17/2004 | CN1141950C Foot bath hypotensor |
| 03/16/2004 | US6706892 Adminstering maleimide derivative to covalently bond protein; wound healing, antibiotic, antiinflammatory, anticarcinogenic, hypotensive, and analgesic agents |
| 03/16/2004 | US6706765 Aminoguanidines and alkoxyguanidines as protease inhibitors |
| 03/16/2004 | US6706751 Dihydroindole and tetrahydroquinoline derivatives |
| 03/16/2004 | US6706750 Useful in treating obesity and other disorders |
| 03/16/2004 | US6706749 Substituted phenyl derivatives, their preparation and use |
| 03/16/2004 | US6706746 Thiadiazolidin-2,4-dione compound |
| 03/16/2004 | US6706743 β3 adrenergic receptor agonists and uses thereof |
| 03/16/2004 | US6706738 Substituted bicyclic heteroaryl compounds and their use as integrin antagonists |
| 03/16/2004 | US6706732 Nasal preparation of guanidinoimino quinoline derivatives |
| 03/16/2004 | US6706731 With isoquinoline derivatives as antitumor agents |
| 03/16/2004 | US6706725 Vitamin D analogues |
| 03/16/2004 | US6706724 Antitumor agents; antiinflammatory agents; analgesics; antipyretic agent |
| 03/16/2004 | US6706723 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 03/16/2004 | US6706720 Heterocyclic dihydropyrimidine compounds |
| 03/16/2004 | US6706719 Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity |
| 03/16/2004 | US6706717 Thiazolyl inhibitors of Tec family tyrosine kinases |
| 03/16/2004 | US6706716 Compounds specific for the human α1d adrenergic receptor and uses thereof |
| 03/16/2004 | US6706715 Reversible inhibitors of the blood clotting enzyme factor viia |
| 03/16/2004 | US6706712 Cyclic derivatives as modulators of chemokine receptor activity |
| 03/16/2004 | US6706711 Substituted diaminopyrazoles; treating diseases, such as cancer, inflammatory disorders, restenosis, and cardiovascular disease. coatings for implantable medical devices, such as prostheses, artificial valves, etc. |
| 03/16/2004 | US6706710 Form of (R)-N-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4-morpholinobenzamide |
| 03/16/2004 | US6706709 Treating, for example, proliferative disorders including cancer |
| 03/16/2004 | US6706707 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles |
| 03/16/2004 | US6706703 Bis(5-aryl-2-pyridyl) compound having excellent immunoglobulin (ige) antibody production inhibiting activity, useful for the prevention or treatment of allergic immune diseases |
| 03/16/2004 | US6706702 For therapy of neurological and psychological disorders |
| 03/16/2004 | US6706698 Anticholesterol agents |
| 03/16/2004 | US6706689 Administering glucagon like peptide-1 (glp-1), where the patient is not suffering from a q-wave myocardial infarction |
| 03/16/2004 | US6706687 Platelet-derived growth factor D |
| 03/16/2004 | US6706686 Inhibition of histone deacetylase as a treatment for cardiac hypertrophy |
| 03/16/2004 | US6706274 Differential delivery of nitric oxide |
| 03/16/2004 | US6706021 Anticoagulant for catheters, dialysis machines, syringes, tubes, blood lines and stents; trypsin-like serine proteases such as thrombin; 3-benzylsulfonylamino-6-methyl-1-((2-guanidinooxyethyl) aminocarbonylmethyl)-2-pyridinone |
| 03/16/2004 | CA2331446C Biodegradable sustained-release alginate gels |
| 03/16/2004 | CA2096460C Dual action inhibitors |
| 03/16/2004 | CA2079143C Novel 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace |
| 03/11/2004 | WO2004020440A1 Di and trifluoro-triazolo-pyridines anti-inflammatory compounds |
| 03/11/2004 | WO2004020435A1 Piperidinyl compounds that selectively bind integrins |
| 03/11/2004 | WO2004020434A1 Azaarene derivatives |
| 03/11/2004 | WO2004020430A2 Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics |
| 03/11/2004 | WO2004020421A1 Novel quaternary ammonium compounds |
| 03/11/2004 | WO2004020412A1 Dihydropyridine derivatives for use as human neutrophil elastase inhibitors |
| 03/11/2004 | WO2004020411A1 Naphthamide derivatives and their use |
| 03/11/2004 | WO2004020393A1 Dibenzylamine compound and medicinal use thereof |
| 03/11/2004 | WO2004019968A1 Methods for preserving organs and tissues |
| 03/11/2004 | WO2004019958A1 Pyrazole derivatives, medicinal composition containing the same, and medicinal use thereof |
| 03/11/2004 | WO2004019946A1 Inhibitors for excessive accumulation of sodium ion in cells |
| 03/11/2004 | WO2004019941A1 Glycinamide derivatives as raf-kinase inhibitors |
| 03/11/2004 | WO2004019940A1 Method of preventing or treating atherosclerosis or restenosis |
| 03/11/2004 | WO2004019939A1 Method of preventing or treating atherosclerosis or restenosis |
| 03/11/2004 | WO2004019936A1 Peroxynitrite rearrangement catalysts used for the treatment or prophylaxis of diseases caused by peroxynitrite-mediated reactions |
| 03/11/2004 | WO2004019926A1 Preventive and/or therapeutic agent for heart failure |
| 03/11/2004 | WO2004019923A1 Compositions comprising vitamin k for treating or preventing age-related stiffening of arteries |